| Characteristics |
HBs Ag |
Anti-HCV Ab |
TPHA |
| Prevalence % (95% CI) |
OR (95% CI) & p value |
Prevalence % (95% CI) |
OR (95% CI) & p value |
Prevalence % (95% CI) |
OR (95% CI) & p value |
| Overall (N= 19 783) |
1.46(1.30-1.64) |
_ |
0.37(0.29-0.47) |
_ |
0.13(0.09-0.20) |
_ |
| Type |
| Replacement (N=12 968) |
1.80(1.60-2.06) |
2.4(1.8-3.2) |
0.50(0.39-0.64) |
3.8(1.9-7.6) |
0.18(0.12-0.27) |
4.2(1.3-14.0) |
| FTNRD (N= 6 815) |
0.77(0.58-1.02) |
P<0.001 |
0.13(0.06-0.26) |
p<0.001 |
0.04(0.01-0.14) |
P=0.08 |
| Gender |
| Male (N= 14 443) |
1.66(1.46-1.89) |
1.9(1.4-2.6) |
0.40(0.31-0.53) |
1.5(0.8-2.6) |
0.14(0.09-0.22) |
1.3(0.5-3.2) |
| Female (N= 5 340) |
0.89(0.67-1.20) |
p<0.001 |
0.28(0.16-0.47) |
P=0.19 |
0.11(0.04-0.25) |
P=0.58 |
| Age group (years) |
| 18-19 (N= 2 888) |
0.65(0.40-1.04) |
1(reference) |
0.03(0.00-0.23) |
1(reference) |
0.00(0,00-0,16) |
1 (reference) |
| 20-29 (N= 8 062) |
1.07(0.87-1,33) |
1.6(1.0-2.7) |
0.26(0.16-0.40) |
7.5(1.0-56.1) |
0.06(0,02-0,15) |
Undefined |
| 30-39 (N= 4 841) |
1.83(1.48-2.26) |
2.8(1.7-4.7) |
0.39(0.24-0.62) |
11.4(1.5-85.0) |
0.10(0,03-0,25) |
Undefined |
| >=40 (N= 3 992) |
2.35(1.91-2.88) |
3.6(2.2-6.0) |
0,82(0.57-1.17) |
24.1(3.3-176.1) |
0.42(0,25-0,69) |
Undefined |
| |
|
P<0.001 |
|
p<0.001 |
|
p<0.001 |
|
